News

Deal Announcements

Amyris Biotechnologies Bags $70 Million Series B

Thursday, September 20, 2007 5:00:00 AM PDT | VentureDeal Staff
EMERYVILLE, CA -- Biofuel maker Amyris Biotechnologies, Inc. announced that it has closed its second round of venture capital financing, securing $70 million.

Amyris is developing synthetic biology technologies to produce bioactive chemical compounds.  The company says that its unique processes give it access to compounds unattainable conventional chemical synthesis.

DAG Ventures lead the round, which included Khosla Ventures, Kleiner Perkins Caufield & Byers and TPG Growth.  The company said it will use the proceeds to scale up its technology to begin producing biofuels in large quantities.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1